Al-Huniti Mohammed H, El-Abadelah Mustafa M, Zahra Jalal A, Sabri Salim S, Ingendoh Arnd
Chemistry Department, Faculty of Science, The University of Jordan, Amman 11942, Jordan.
Molecules. 2007 Mar 15;12(3):497-503. doi: 10.3390/12030497.
Model tetrahydropyrido[3',2':4,5]thieno[2,3-b][1,4]thiazines 9a-c were synthesized via reductive lactamization, using sodium dithionite, of the respective 2-[(carboxyalkyl)thio]-3-nitro-4,7-dihydrothieno[2,3-b]pyridine-5-carboxylic acids 7a-c. The latter derivatives were made via interaction of 2-chloro-7-cyclopropyl-3-nitro-4,7-dihydrothieno[2,3-b]pyridine-5-carboxylic acid (6) with each of alpha-mercaptoacetic, alpha-mercaptopropionic, and alpha-mercaptosuccinic acids and triethylamine in aqueous acetone at room temperature. The structures of 7a-7c and 9a-9c are supported by microanalytical and spectral (IR, MS, NMR) data. Compounds 9a and 9c showed potent inhibitory activity against the IGROV1 (Ovarian Cancer) cell line.
通过使用连二亚硫酸钠对相应的2-[(羧基烷基)硫基]-3-硝基-4,7-二氢噻吩并[2,3-b]吡啶-5-羧酸7a-c进行还原内酰胺化反应,合成了模型四氢吡啶并[3',2':4,5]噻吩并[2,3-b][1,4]噻嗪9a-c。后一种衍生物是通过2-氯-7-环丙基-3-硝基-4,7-二氢噻吩并[2,3-b]吡啶-5-羧酸(6)与α-巯基乙酸、α-巯基丙酸和α-巯基琥珀酸以及三乙胺在室温下于丙酮水溶液中相互作用制得的。7a-7c和9a-9c的结构得到了微量分析和光谱(红外、质谱、核磁共振)数据的支持。化合物9a和9c对IGROV1(卵巢癌)细胞系表现出强效抑制活性。